AstraZeneca In The “Transparency” Era: An Interview With CEO David Brennan
Executive Summary
If you visit AstraZeneca's offices in Washington, D.C., your name has to be on a list. After you get your badge, you show it at the elevator bank to a guard, who, in a throwback to operators of yore, steps inside with you to unlock the keypad and send you on your way
You may also be interested in...
AstraZeneca CEO Brennan Talks About Cutting Deals and Dealing With Change
PhRMA's new chairman, AstraZeneca CEO David Brennan, wants to make a deal on health reform - but not necessarily the kind of tradeoff the industry made on the Medicare drug benefit
AstraZeneca CEO Brennan Talks About Cutting Deals and Dealing With Change
PhRMA's new chairman, AstraZeneca CEO David Brennan, wants to make a deal on health reform - but not necessarily the kind of tradeoff the industry made on the Medicare drug benefit
PhRMA’s DTC Principles: After Two Years, Still A Work In Progress
According to recent polling, Americans have a reasonably favorable opinion of direct-to-consumer advertising, but the pharmaceutical industry still sees potential trouble based on how the public perceives the practice